» Articles » PMID: 20010955

Ischemic Preconditioning Regulates Expression of MicroRNAs and a Predicted Target, MeCP2, in Mouse Cortex

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Preconditioning describes the ischemic stimulus that triggers an endogenous, neuroprotective response that protects the brain during a subsequent severe ischemic injury, a phenomenon known as 'tolerance'. Ischemic tolerance requires new protein synthesis, leads to genomic reprogramming of the brain's response to subsequent ischemia, and is transient. MicroRNAs (miRNAs) regulate posttranscriptional gene expression by exerting direct effects on messenger RNA (mRNA) translation. We examined miRNA expression in mouse cortex in response to preconditioning, ischemic injury, and tolerance. The results of our microarray analysis revealed that miRNA expression is consistently altered within each group, but that preconditioning was the foremost regulator of miRNAs. Our bioinformatic analysis results predicted that preconditioning-regulated miRNAs most prominently target mRNAs that encode transcriptional regulators; methyl-CpG binding protein 2 (MeCP2) was the most prominent target. No studies have linked MeCP2 to preconditioning or tolerance, yet miR-132, which regulates MeCP2 expression, is decreased in preconditioned cortex. Downregulation of miR-132 is consistent with our finding that preconditioning ischemia induces a rapid increase in MeCP2 protein, but not mRNA, in mouse cortex. These studies reveal that ischemic preconditioning regulates expression of miRNAs and their predicted targets in mouse brain cortex, and further suggest that miRNAs and MeCP2 could serve as effectors of ischemic preconditioning-induced tolerance.

Citing Articles

Brain Ischemic Tolerance Triggered by Preconditioning Involves Modulation of Tumor Necrosis Factor-α-Stimulated Gene 6 (TSG-6) in Mice Subjected to Transient Middle Cerebral Artery Occlusion.

Di Santo C, Siniscalchi A, La Russa D, Tonin P, Bagetta G, Amantea D Curr Issues Mol Biol. 2024; 46(9):9970-9983.

PMID: 39329947 PMC: 11430743. DOI: 10.3390/cimb46090595.


Physiological and cellular mechanisms of ischemic preconditioning microRNAs-mediated in underlying of ischemia/reperfusion injury in different organs.

Gheitasi I, Akbari G, Savari F Mol Cell Biochem. 2024; 480(2):855-868.

PMID: 39001984 DOI: 10.1007/s11010-024-05052-7.


MicroRNA Profiles in Critically Ill Patients.

Alikiaii B, Bagherniya M, Askari G, Rajendram R, Sahebkar A Curr Med Chem. 2023; 31(41):6801-6825.

PMID: 37496239 DOI: 10.2174/0929867331666230726095222.


Potential mechanisms underlying the association between type II diabetes mellitus and cognitive dysfunction in rats: a link between miRNA-21 and Resveratrol's neuroprotective action.

El-Sayed N, Elatrebi S, Said R, Ibrahim H, Omar E Metab Brain Dis. 2022; 37(7):2375-2388.

PMID: 35781592 PMC: 9581846. DOI: 10.1007/s11011-022-01035-z.


Ischemic Preconditioning Modulates the Peripheral Innate Immune System to Promote Anti-Inflammatory and Protective Responses in Mice Subjected to Focal Cerebral Ischemia.

Amantea D, La Russa D, Frisina M, Giordano F, Di Santo C, Panno M Front Immunol. 2022; 13:825834.

PMID: 35359933 PMC: 8962743. DOI: 10.3389/fimmu.2022.825834.


References
1.
Perez-Pinzon M, Xu G, Dietrich W, Rosenthal M, Sick T . Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J Cereb Blood Flow Metab. 1997; 17(2):175-82. DOI: 10.1097/00004647-199702000-00007. View

2.
Schratt G, Tuebing F, Nigh E, Kane C, Sabatini M, Kiebler M . A brain-specific microRNA regulates dendritic spine development. Nature. 2006; 439(7074):283-9. DOI: 10.1038/nature04367. View

3.
Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N . Widespread changes in protein synthesis induced by microRNAs. Nature. 2008; 455(7209):58-63. DOI: 10.1038/nature07228. View

4.
Dirnagl U, Becker K, Meisel A . Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009; 8(4):398-412. PMC: 2668955. DOI: 10.1016/S1474-4422(09)70054-7. View

5.
Fischer M, Reuter J, Gerich F, Hildebrandt B, Hagele S, Katschinski D . Enhanced hypoxia susceptibility in hippocampal slices from a mouse model of rett syndrome. J Neurophysiol. 2008; 101(2):1016-32. DOI: 10.1152/jn.91124.2008. View